Related Experiment Video

Updated: Aug 30, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

Sexually transmitted infection/HIV laboratory testing in resource-limited countries: steps to improve use effective

Elizabeth Donegan1, Jeanne Moncada, Max Chernesky

  • 1Department of Anesthesiology, University of California Medical Center, San Francisco, California 94143, USA. donegane@anesthesia.ucsf.edu

Sexually Transmitted Diseases
|December 4, 2003
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

Related Experiment Videos

Last Updated: Aug 30, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...

Articles linked to this work by shared authors, journal, and citation graph.

Chlamydia and Gonorrhea Infections in Genital and Extragenital Samples Among Men and Women.

Sexually transmitted diseases·2025

HPV genotype-specific distribution and attributable risk in cervical intraepithelial neoplasia in a referral population with a history of LSIL.

Cancer biomarkers : section A of Disease markers·2023

Comparison of CINtec PLUS cytology and cobas HPV test for triaging Canadian patients with LSIL cytology referred to colposcopy: A two-year prospective study.

Cancer biomarkers : section A of Disease markers·2022

Multicenter Comparison of Nucleic Acid Amplification Tests for the Diagnosis of Rectal and Oropharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae Infections.

Journal of clinical microbiology·2021

Comparison of Alinity m HPV and cobas HPV assays on cervical specimens in diverse storage media.

Tumour virus research·2021

Workflow and Throughput of Commercial Assays to Detect Mycoplasma genitalium and Macrolide Resistance-Mediating Mutations.

Sexually transmitted diseases·2021

Patterns of Sexually Transmitted Infection-Related Testing and Diagnosis by Places of Service, MarketScan Commercial Claims Data, 2023-2024.

Sexually transmitted diseases·2026

Chlamydia and Gonorrhea Prevalence in Women Entering the North Carolina Department of Adult Corrections, 2013-2019.

Sexually transmitted diseases·2026

Screening for Sexually Transmitted Infections during pregnancy: Is healthcare meeting expectations?

Sexually transmitted diseases·2026

Changes in providers diagnosing sexually transmitted infections in Louisiana, 2018-2024.

Sexually transmitted diseases·2026

"Really just recognizing that women also have sex.": A qualitative analysis of cisgender women's self-reported barriers to accessing PrEP.

Sexually transmitted diseases·2026

"Actually, that's one of the reasons I stopped getting tested often, because I didn't want to be judged:" Sexual Healthcare and STI Testing Experiences Among U.S. Men Who Have Sex With Men.

Sexually transmitted diseases·2026

Correction: Mijović et al. Health in All Policies in Sectoral Legislation: A Content Analysis of Selected Laws in the Republic of Srpska. Healthcare 2026, 14, 2139.

Healthcare (Basel, Switzerland)·2026

Reducing referrals in primary care through specialist-supported telehealth: quasi-experimental evidence from Northeast Brazil.

Frontiers in digital health·2026

Differing influenza vaccine uptake and recommendation behavior among healthcare workers in primary health centers, secondary and tertiary hospitals, and schools in a metropolis of southern China.

Expert review of vaccines·2026

Service delivery interventions for lipid testing and lipid-lowering therapy for primary and secondary prevention of cardiovascular disease in adults.

The Cochrane database of systematic reviews·2026

The community drug distributor passport: a case study of training and recognition in Chad.

Frontiers in public health·2026

Cervical cancer screening in Sub-Saharan Africa: A scoping review of test and treat and test, triage and treat approaches.

Public health·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us